Classic Hodgkin Lymphoma — Trials

Classic Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 32.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 51–66 of 66 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03226249	PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma	unknown	Phase 2	30	Northwestern UniversityOTHER	1	Jun 2, 2023	clinicaltrials
NCT05833984	Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas	unknown	Phase 1 / Phase 2	309	ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER	1	Apr 27, 2023